-
EP1455829
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1455829
| EP1455829 - TREATING VASCULAR DISEASE BY INHIBITING MYELOID DIFFERENTIATION FACTOR 88 [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 23.06.2006 Database last updated on 04.06.2024 | Most recent event Tooltip | 23.06.2006 | Application deemed to be withdrawn | published on 26.07.2006 [2006/30] | Applicant(s) | For all designated states Cedars-Sinai Medical Center 8700 Beverly Boulevard Los Angeles, CA 90048 / US | [N/P] |
| Former [2004/38] | For all designated states CEDARS-SINAI MEDICAL CENTER 8700 Beverly Boulevard Los Angeles, California 90048-1865 / US | Inventor(s) | 01 /
ARDITI, M., C/O Cedars-Sinai Med. Center 8700 Beverly Boulevard, Schuman Trailer Los Angeles, CA 90048 / US | 02 /
RAJAVASHISTH, T B., C/O Cedars-Sinai Med. Center Davis Research Bldg. D-1062, 8700 Beverly Blvd. Los Angeles, CA 90048 / US | 03 /
SHAH, P., K., C/O Cedars-Sinai Med. Center. 8700 Beverly Blvd. Room 5314 Los Angeles, CA 90048 / US | [2004/38] | Representative(s) | Banford, Paul Clifford, et al Marks & Clerk LLP 1 New York Street Manchester, M1 4HD / GB | [N/P] |
| Former [2004/38] | Banford, Paul Clifford, et al Marks & Clerk, 43 Park Place Leeds LS1 2RY / GB | Application number, filing date | 02791415.9 | 12.12.2002 | [2004/38] | WO2002US39932 | Priority number, date | US20010341359P | 17.12.2001 Original published format: US 341359 P | US20020128166 | 23.04.2002 Original published format: US 128166 | [2004/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO03051396 | Date: | 26.06.2003 | Language: | EN | [2003/26] | Type: | A1 Application with search report | No.: | EP1455829 | Date: | 15.09.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.06.2003 takes the place of the publication of the European patent application. | [2004/38] | Search report(s) | International search report - published on: | EP | 26.06.2003 | Classification | IPC: | A61K45/00, A61L31/16, A61K31/7105, A61K38/17, A61K39/395 | [2004/38] | CPC: |
A61L29/16 (EP,US);
A61L31/16 (EP,US);
A61P9/00 (EP);
A61P9/10 (EP);
C07K14/705 (EP,US);
C12N15/113 (EP,US);
A61K2039/505 (EP,US);
A61K38/00 (EP,US);
A61L2300/258 (EP,US);
A61L2300/416 (EP,US);
A61L2300/422 (EP,US);
A61L2300/436 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2004/38] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | Title | German: | BEHANDLUNG VON GEFÄSSERKRANKUNGEN DURCH INHIBIERUNG DES MYELOID-DIFFERENZIERUNGSFAKTORS 88 | [2004/38] | English: | TREATING VASCULAR DISEASE BY INHIBITING MYELOID DIFFERENTIATION FACTOR 88 | [2004/38] | French: | TRAITEMENT DE MALADIE VASCULAIRE PAR INHIBITION DU FACTEUR 88 DE DIFFERENCIATION MYELOIDE | [2004/38] | Entry into regional phase | 23.06.2004 | National basic fee paid | 23.06.2004 | Designation fee(s) paid | 23.06.2004 | Examination fee paid | Examination procedure | 10.07.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 15.06.2004 | Amendment by applicant (claims and/or description) | 23.06.2004 | Examination requested [2004/41] | 14.07.2005 | Despatch of a communication from the examining division (Time limit: M06) | 25.01.2006 | Application deemed to be withdrawn, date of legal effect [2006/30] | 28.02.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2006/30] | Fees paid | Renewal fee | 14.12.2004 | Renewal fee patent year 03 | 27.12.2005 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US5591227 (DINH THOMAS Q [US], et al) [Y] 1-26 * column 2, line 36 - line 56 *; | [Y]US5733327 (IGAKI KEIJI [JP], et al) [Y] 1-26 * column 2, line 54 - column 3, line 18; examples 1-7 *; | [Y]US6171609 (KUNZ LAWRENCE L [US]) [Y] 1-26 * column 4, line 8 - line 43; claim 1 *; | [XY]WO0188137 (IMMUNEX CORP [US], et al) [X] 27-56 * page 22, line 5 - line 12 * * page 26, line 12 - line 26 * [Y] 1-26; | [A] - FITZGERALD K A ET AL, "Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, (20010906), vol. 413, ISSN 0028-0836, pages 78 - 83, XP002190965 [A] 1-56 * the whole document * DOI: http://dx.doi.org/10.1038/35092578 | [A] - BURNS K ET AL, "MYD88, AN ADAPTER PROTEIN INVOLVED IN INTERLEUKIN-1 SIGNALING", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, (19980515), vol. 273, no. 20, ISSN 0021-9258, pages 12203 - 12209, XP000985939 [A] 1-56 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.273.20.12203 |